Harrow Health (HROW) Tops Q2 EPS by 3c
Tweet
Share
E-mailGet Alerts HROW Hot Sheet
Join SI Premium – FREE
Harrow Health (NASDAQ: HROW) reported Q2 EPS of $0.01, $0.03 better than the analyst estimate of ($0.02). Revenue for the quarter came in at $23.3 million versus the consensus estimate of $22.07 million.
For earnings history and earnings-related data on Harrow Health (HROW) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Stran & Company, Inc. (SWAG) Reports Q2 EPS of $0.02
- National CineMedia (NCMI) Misses Q2 EPS by 7c
- Kyverna Therapeutics, Inc. (KYTX) Tops Q2 EPS by 45c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
